Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Tag: FDA

FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

Americas
Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...

FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

Americas
The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

FDA Approvals
Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...

The U.S. FDA Approved Papzimeos for RRP Treatment in Adults

Americas
The U.S. Food and Drug Administration granted approval for Papzimeos (zopapogene imadenovec-drba), marking the introduction of a first-of-its-kind, non-replicating adenoviral vector-based immunotherapy for adult...

FDA Approves Brinsupri by Insmed for Chronic Lung Condition

Americas
The U.S. Food and Drug Administration, FDA approves Brinsupri, Insmed's oral drug for a lung disease, the company announced. This marks the first treatment...
1...678Page 7 of 8

Popular

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.